☆ 4.1 Article

Cost-effectiveness of 3-years of adjuvant imatinib in gastrointestinal stromal tumors (GIST) in the United States

JOURNAL OF MEDICAL ECONOMICS (2012)

Journal

JOURNAL OF MEDICAL ECONOMICS

Volume 16, Issue 1, Pages 150-159

Publisher

Informa Healthcare

DOI: 10.3111/13696998.2012.709204

Keywords

-

Categories

Medicine, General & Internal

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.